COHORT ORD 10P news, videos and press releases
For more news please use our advanced search feature.
COHORT ORD 10P - More news...
COHORT ORD 10P - More news...
- Avidity Biosciences Completes Enrollment in Biomarker Cohort in Phase 1/2 FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax) in People Living with Facioscapulohumeral Muscular Dystrophy
- TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138
- App Orchid Chosen for Plug and Play's Leading Innovation Cohort
- TransCode Therapeutics Announces Safety Review Committee Approval to Open Fourth Cohort in Phase I/II Clinical Trial
- Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
- Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort
- TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial
- TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial
- TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial
- $1M Non-Dilutive Grants Fuel Innovation: Meet MassRobotics Latest Accelerator Cohort
- Chef Ann Foundation Announces 2025 Healthy School Food Pathway Fellowship Cohort
- Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain
- Salv opens applications for Bridge cohort to protect customers from APP fraud and disrupt criminal networks
- TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial
- MassRobotics Unveils the 2025 Healthcare Robotics Startup Catalyst Cohort
- TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial
- Chef Ann Foundation Announces the Sixth Cohort of Get Schools Cooking
- Palantir’s Inaugural Warp Speed Cohort to Power Manufacturing and Production Capabilities Through Advanced AI & Technology
- Mission1st Group, Inc./Ardent Graduates From MissionLink’s 2024 Cohort; Joins Esteemed Alumni Network
- Teach Access Announces Its National Fellowship 2025 Cohort
- Avangrid Continues to Provide State-of-the-Art Training to New Hires at National Training Center, Second Cohort Graduates
- Oncolytics Biotech® Reports Completion of Initial Safety Phase Enrollment for GOBLET Trial's New Pancreatic Cancer Cohort
- Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Cohort in The Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients
- Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
- Aileron Therapeutics Announces Positive Topline Data from Cohort 2 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
- Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
- Avidity Biosciences Pursues Potential Accelerated Approval Path with Initiation of Biomarker Cohort in FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax/AOC 1020) in People Living with Facioscapulohumeral Muscular Dystrophy
- Sundance Institute and Gold House Announce Second Cohort of 'One House Filmmakers Fund', Made Possible With Funding From the East West Bank Foundation
- Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection Fraction
- A Joint Regional Cohort Study by Shimadzu, Eisai, Oita University, and Usuki City Medical Association
